These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 24621187)

  • 1. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
    Seyednejad N; Kuusk U; Wiseman SM
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary reverse mapping (ARM): where to go.
    Shao X; Sun B; Shen Y
    Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary reverse mapping for breast cancer.
    Noguchi M
    Breast Cancer Res Treat; 2010 Feb; 119(3):529-35. PubMed ID: 19842033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is axillary reverse mapping feasible in breast cancer patients?
    Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
    Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
    Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
    PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
    Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
    Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla -- a lesson from the past -- contribution to the concept of axillary reverse mapping.
    Pavlista D; Eliska O
    Eur J Surg Oncol; 2012 May; 38(5):390-4. PubMed ID: 22336143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
    Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
    Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
    Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J
    Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary reverse mapping: five-year experience.
    Ochoa D; Korourian S; Boneti C; Adkins L; Badgwell B; Klimberg VS
    Surgery; 2014 Nov; 156(5):1261-8. PubMed ID: 25444319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
    Noguchi M; Noguchi M; Ohno Y; Morioka E; Nakano Y; Kosaka T; Kurose N; Minato H
    Eur J Surg Oncol; 2016 May; 42(5):650-6. PubMed ID: 27005806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].
    Gobardhan PD; Klompenhouwer EG; Beek MA; Voogd AC; Luiten EJ
    Ned Tijdschr Geneeskd; 2013; 157(22):A5646. PubMed ID: 23714290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
    Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
    Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
    Trials; 2013 Apr; 14():111. PubMed ID: 23782712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.